Clinical Trials · NCT04867785
A Study of LY3437943 in Participants With Type 2 Diabetes
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 281
- Start date
- May 2021
- Locations
- 43 sites, United States, Puerto Rico
- Primary endpoint
- Change From Baseline in Hemoglobin A1c (HbA1c)